var eventsData = [{"Ticker":"CCE","EffectiveDate":"2017-01-11","Type":"RatingUpgrade","Title":"UBS upgrades CCE to Buy from Neutral. Target Price is $38; previously $35.","DailyReturn":"3.17%","FiveDayReturnAfter":"4.59%","FiveDayReturnBefore":"0.41%"},{"Ticker":"CCE","EffectiveDate":"2017-01-09","Type":"RatingNeutral","Title":"Barclays initiates coverage on CCE to Overweight.","DailyReturn":"0.09%","FiveDayReturnAfter":"0.68%","FiveDayReturnBefore":"1.1%"},{"Ticker":"CCE","EffectiveDate":"2016-12-28","Type":"Dividend","Title":"The Firm pays dividend $0.178","DailyReturn":"-0.35%","FiveDayReturnAfter":"-0.44%","FiveDayReturnBefore":"-1.55%"},{"Ticker":"CCE","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades CCE to Hold from Buy.","DailyReturn":"-0.88%","FiveDayReturnAfter":"1.69%","FiveDayReturnBefore":"-5.78%"},{"Ticker":"CCE","EffectiveDate":"2016-11-10","Type":"EarningsRevenueMiss","Title":"Before market open, CCE reports 2016 Q3's earning $0.72 per share and revenue $3255MM. This misses analyst's estimated EPS $0.74, misses estimated revenue $3270MM.","DailyReturn":"-8.75%","FiveDayReturnAfter":"-9.76%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"CCE","EffectiveDate":"2016-10-20","Type":"RatingNeutral","Title":"Kepler Cheuvreux initiates coverage on CCE to Buy.","DailyReturn":"-0.47%","FiveDayReturnAfter":"0.31%","FiveDayReturnBefore":"-0.07%"},{"Ticker":"CCE","EffectiveDate":"2016-10-10","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCE to Neutral from Buy.","DailyReturn":"-2.52%","FiveDayReturnAfter":"-2.29%","FiveDayReturnBefore":"-2.66%"},{"Ticker":"CCE","EffectiveDate":"2016-09-29","Type":"Dividend","Title":"The Firm pays dividend $0.19","DailyReturn":"-0.33%","FiveDayReturnAfter":"-0.38%","FiveDayReturnBefore":"-0.88%"},{"Ticker":"CCE","EffectiveDate":"2016-09-22","Type":"EarningsMissRevenueBeat","Title":"Before market open, CCE reports 2016 Q2's earning $0.63 per share and revenue $3218MM. This misses analyst's estimated EPS $0.72, beats estimated revenue $3040MM.","DailyReturn":"1.3%","FiveDayReturnAfter":"-0.88%","FiveDayReturnBefore":"0.12%"},{"Ticker":"CCE","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on CCE to Neutral.","DailyReturn":"0.22%","FiveDayReturnAfter":"0.12%","FiveDayReturnBefore":"-1.27%"},{"Ticker":"CCE","EffectiveDate":"2016-07-19","Type":"RatingUpgrade","Title":"Societe Generale upgrades CCE to Buy from Hold.","DailyReturn":"1.35%","FiveDayReturnAfter":"2.87%","FiveDayReturnBefore":"3.63%"},{"Ticker":"CCE","EffectiveDate":"2016-06-10","Type":"RatingNeutral","Title":"Deutsche Bank assumes CCE to Buy. Target Price is $47.","DailyReturn":"-2.4%","FiveDayReturnAfter":"-5.86%","FiveDayReturnBefore":"0%"},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"Barclays maintains CCE to Equal-Weight. Target Price is $40; previously $54.","DailyReturn":"1.15%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"7.49%"},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"Bank of America initiates coverage on CCE to Buy.","DailyReturn":"1.15%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"7.49%"},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"CLSA maintains CCE to Outperform. Target Price is $45; previously $60.","DailyReturn":"1.15%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"7.49%"},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"Dividend","Title":"The Firm pays dividend $14.5","DailyReturn":"4.75%","FiveDayReturnAfter":"6.35%","FiveDayReturnBefore":"1.66%"},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CCE to Buy.","DailyReturn":"4.75%","FiveDayReturnAfter":"6.35%","FiveDayReturnBefore":"1.66%"},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades CCE to Buy from Hold.","DailyReturn":"4.75%","FiveDayReturnAfter":"6.35%","FiveDayReturnBefore":"1.66%"},{"Ticker":"CCE","EffectiveDate":"2016-05-16","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":"0.38%","FiveDayReturnAfter":"-3.56%","FiveDayReturnBefore":"-2.26%"},{"Ticker":"CCE","EffectiveDate":"2016-04-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2016 Q1's earning $0.41 per share and revenue $1517MM. This beats analyst's estimated EPS $0.4, misses estimated revenue $1550MM.","DailyReturn":"3.73%","FiveDayReturnAfter":"1.64%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"CCE","EffectiveDate":"2016-04-14","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades CCE to Buy from Hold.","DailyReturn":"0.94%","FiveDayReturnAfter":"-0.26%","FiveDayReturnBefore":"0.54%"},{"Ticker":"CCE","EffectiveDate":"2016-03-02","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":"-0.53%","FiveDayReturnAfter":"0.49%","FiveDayReturnBefore":"-0.02%"},{"Ticker":"CCE","EffectiveDate":"2016-02-05","Type":"RatingUpgrade","Title":"Susquehanna upgrades CCE to Neutral from Negative. Target Price is $43; previously $45.","DailyReturn":"0%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"1.46%"},{"Ticker":"CCE","EffectiveDate":"2016-01-25","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $49; previously $52.","DailyReturn":"0.61%","FiveDayReturnAfter":"2.35%","FiveDayReturnBefore":"-1.83%"},{"Ticker":"CCE","EffectiveDate":"2015-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"1.15%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-1.18%"},{"Ticker":"CCE","EffectiveDate":"2015-09-02","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"1.75%","FiveDayReturnAfter":"-3.06%","FiveDayReturnBefore":"1.12%"},{"Ticker":"CCE","EffectiveDate":"2015-08-13","Type":"RatingUpgrade","Title":"CLSA upgrades CCE to Outperform from Underperform. Target Price is $60; previously $56.","DailyReturn":"-0.68%","FiveDayReturnAfter":"-0.53%","FiveDayReturnBefore":"1.87%"},{"Ticker":"CCE","EffectiveDate":"2015-08-07","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $56; previously $48.","DailyReturn":"-3.14%","FiveDayReturnAfter":"-1.75%","FiveDayReturnBefore":"16.12%"},{"Ticker":"CCE","EffectiveDate":"2015-08-06","Type":"RatingNeutral","Title":"Argus Research downgrades CCE to Sell from Buy.","DailyReturn":"2.99%","FiveDayReturnAfter":"1.87%","FiveDayReturnBefore":"11.51%"},{"Ticker":"CCE","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Barclays maintains CCE to Equal-Weight. Target Price is $49; previously $48.","DailyReturn":"12.41%","FiveDayReturnAfter":"16.12%","FiveDayReturnBefore":"0.06%"},{"Ticker":"CCE","EffectiveDate":"2015-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"0.43%","FiveDayReturnAfter":"-2.71%","FiveDayReturnBefore":"0%"},{"Ticker":"CCE","EffectiveDate":"2015-05-27","Type":"RatingUpgrade","Title":"HSBC upgrades CCE to Buy from Neutral. Target Price is $48; previously $50.","DailyReturn":"1.44%","FiveDayReturnAfter":"0%","FiveDayReturnBefore":"-4.75%"},{"Ticker":"CCE","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Susquehanna maintains CCE to Negative. Target Price is $28; previously $33.","DailyReturn":"-2.07%","FiveDayReturnAfter":"-3.52%","FiveDayReturnBefore":"2.18%"},{"Ticker":"CCE","EffectiveDate":"2015-04-14","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on CCE to Negative. Target Price is $33.","DailyReturn":"-1.01%","FiveDayReturnAfter":"-0.13%","FiveDayReturnBefore":"-1.21%"},{"Ticker":"CCE","EffectiveDate":"2015-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"-1.64%","FiveDayReturnAfter":"-6.33%","FiveDayReturnBefore":"1.2%"},{"Ticker":"CCE","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $43; previously $40.","DailyReturn":"-1.48%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"2.65%"},{"Ticker":"CCE","EffectiveDate":"2015-01-26","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $40; previously $42.","DailyReturn":"-0.11%","FiveDayReturnAfter":"-2.92%","FiveDayReturnBefore":"2.54%"},{"Ticker":"CCE","EffectiveDate":"2015-01-05","Type":"RatingUpgrade","Title":"Bank of America upgrades CCE to Buy from Neutral. Target Price is $52; previously $50.","DailyReturn":"0.77%","FiveDayReturnAfter":"-0.25%","FiveDayReturnBefore":"-2.74%"},{"Ticker":"CCE","EffectiveDate":"2014-12-19","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $42; previously $41.","DailyReturn":"1.15%","FiveDayReturnAfter":"1.94%","FiveDayReturnBefore":"0.02%"},{"Ticker":"CCE","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $41; previously $42.","DailyReturn":"1.23%","FiveDayReturnAfter":"-2.28%","FiveDayReturnBefore":"-0.36%"},{"Ticker":"CCE","EffectiveDate":"2014-11-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.43%","FiveDayReturnAfter":"1.12%","FiveDayReturnBefore":"2.5%"},{"Ticker":"CCE","EffectiveDate":"2014-10-31","Type":"RatingNeutral","Title":"Nomura downgrades CCE to Reduce from Neutral. Target Price is $42.","DailyReturn":"0.51%","FiveDayReturnAfter":"-0.62%","FiveDayReturnBefore":"2.17%"},{"Ticker":"CCE","EffectiveDate":"2014-10-06","Type":"RatingUpgrade","Title":"Nomura upgrades CCE to Neutral from Reduce. Target Price is $43; previously $39.","DailyReturn":"-0.54%","FiveDayReturnAfter":"-5.93%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"CCE","EffectiveDate":"2014-09-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.87%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"-0.33%"},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $53; previously $50.","DailyReturn":"-1.53%","FiveDayReturnAfter":"-7.11%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"UBS maintains CCE to Neutral. Target Price is $52; previously $51.","DailyReturn":"-1.53%","FiveDayReturnAfter":"-7.11%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"JP Morgan maintains CCE to Neutral. Target Price is $53; previously $48.","DailyReturn":"-1.53%","FiveDayReturnAfter":"-7.11%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CCE","EffectiveDate":"2014-07-16","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $52; previously $50.","DailyReturn":"0.47%","FiveDayReturnAfter":"0.45%","FiveDayReturnBefore":"1.29%"},{"Ticker":"CCE","EffectiveDate":"2014-06-09","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CCE to Hold. Target Price is $45.","DailyReturn":"0.26%","FiveDayReturnAfter":"-2.39%","FiveDayReturnBefore":"0.59%"},{"Ticker":"CCE","EffectiveDate":"2014-06-04","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.16%","FiveDayReturnAfter":"-0.33%","FiveDayReturnBefore":"0.81%"},{"Ticker":"CCE","EffectiveDate":"2014-05-28","Type":"RatingNeutral","Title":"ISI Group initiates coverage on CCE to Neutral. Target Price is $50.","DailyReturn":"1.21%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"-3.25%"},{"Ticker":"CCE","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Nomura downgrades CCE to Reduce from Neutral. Target Price is $41; previously $44.5.","DailyReturn":"-0.93%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"1.84%"},{"Ticker":"CCE","EffectiveDate":"2014-03-05","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.64%","FiveDayReturnAfter":"0.49%","FiveDayReturnBefore":"-0.1%"},{"Ticker":"CCE","EffectiveDate":"2014-03-04","Type":"RatingNeutral","Title":"UBS initiates coverage on CCE to Neutral.","DailyReturn":"1.07%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-1.72%"},{"Ticker":"CCE","EffectiveDate":"2014-02-14","Type":"RatingNeutral","Title":"HSBC downgrades CCE to Neutral from Overweight. Target Price is $49; previously $47.","DailyReturn":"0.41%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"3.9%"},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $43.5; previously $42.","DailyReturn":"1.76%","FiveDayReturnAfter":"2.88%","FiveDayReturnBefore":"3.55%"},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $45; previously $44.","DailyReturn":"1.76%","FiveDayReturnAfter":"2.88%","FiveDayReturnBefore":"3.55%"},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $47; previously $45.","DailyReturn":"1.76%","FiveDayReturnAfter":"2.88%","FiveDayReturnBefore":"3.55%"},{"Ticker":"CCE","EffectiveDate":"2013-11-26","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CCE to Outperform. Target Price is $49.","DailyReturn":"1.13%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"-0.81%"},{"Ticker":"CCE","EffectiveDate":"2013-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"-0.38%","FiveDayReturnAfter":"1%","FiveDayReturnBefore":"-0.14%"},{"Ticker":"CCE","EffectiveDate":"2013-10-25","Type":"RatingNeutral","Title":"Societe Generale downgrades CCE to Hold from Buy.","DailyReturn":"1.8%","FiveDayReturnAfter":"3.11%","FiveDayReturnBefore":"-3.54%"},{"Ticker":"CCE","EffectiveDate":"2013-10-08","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $45; previously $40.","DailyReturn":"-0.25%","FiveDayReturnAfter":"3.09%","FiveDayReturnBefore":"-1.05%"},{"Ticker":"CCE","EffectiveDate":"2013-09-04","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"1.04%","FiveDayReturnAfter":"3.38%","FiveDayReturnBefore":"3.48%"},{"Ticker":"CCE","EffectiveDate":"2013-09-03","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CCE to Buy from Neutral. Target Price is $47.","DailyReturn":"3.04%","FiveDayReturnAfter":"6.16%","FiveDayReturnBefore":"-0.5%"},{"Ticker":"CCE","EffectiveDate":"2013-07-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2013 Q2's earning $0.77 per share and revenue $2160MM. This beats analyst's estimated EPS $0.76, misses estimated revenue $2220MM.","DailyReturn":"1.84%","FiveDayReturnAfter":"0.1%","FiveDayReturnBefore":"1.15%"},{"Ticker":"CCE","EffectiveDate":"2013-07-18","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $38; previously $35.","DailyReturn":"-0.08%","FiveDayReturnAfter":"1.15%","FiveDayReturnBefore":"2.98%"},{"Ticker":"CCE","EffectiveDate":"2013-06-14","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $35; previously $37.","DailyReturn":"-0.33%","FiveDayReturnAfter":"-4.74%","FiveDayReturnBefore":"-1.28%"},{"Ticker":"CCE","EffectiveDate":"2013-06-05","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"-1.6%","FiveDayReturnAfter":"-4.11%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"CCE","EffectiveDate":"2013-05-16","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades CCE to Hold from Buy; previously $40.","DailyReturn":"-1.25%","FiveDayReturnAfter":"-2.79%","FiveDayReturnBefore":"4.22%"},{"Ticker":"CCE","EffectiveDate":"2013-04-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2013 Q1's earning $0.39 per share and revenue $1900MM. This beats analyst's estimated EPS $0.38, misses estimated revenue $1920MM.","DailyReturn":"-2.17%","FiveDayReturnAfter":"-0.82%","FiveDayReturnBefore":"0.51%"},{"Ticker":"CCE","EffectiveDate":"2013-04-16","Type":"RatingUpgrade","Title":"Societe Generale upgrades CCE to Buy from Hold. Target Price is $42.5; previously $37.","DailyReturn":"2.66%","FiveDayReturnAfter":"1.14%","FiveDayReturnBefore":"-0.82%"},{"Ticker":"CCE","EffectiveDate":"2013-04-01","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCE to Neutral from Buy. Target Price is $40.","DailyReturn":"-1.43%","FiveDayReturnAfter":"-2.52%","FiveDayReturnBefore":"0.1%"},{"Ticker":"CCE","EffectiveDate":"2013-03-06","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"-0.8%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"2.95%"},{"Ticker":"CCE","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCE to Buy. Target Price is $40; previously $36.","DailyReturn":"1.34%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"0.14%"},{"Ticker":"CCE","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"UBS maintains CCE to Buy. Target Price is $39; previously $34.","DailyReturn":"1.34%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"0.14%"},{"Ticker":"CCE","EffectiveDate":"2013-02-07","Type":"EarningBeat","Title":"Before market open, CCE reports 2012 Q4's earning $0.45 per share and revenue $1920MM. This beats analyst's estimated EPS $0.43, meets estimated revenue $1920MM.","DailyReturn":"0.05%","FiveDayReturnAfter":"1.3%","FiveDayReturnBefore":"0.51%"},{"Ticker":"CCE","EffectiveDate":"2013-01-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $35; previously $33.","DailyReturn":"0.32%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"3%"},{"Ticker":"CCE","EffectiveDate":"2012-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.7%","FiveDayReturnAfter":"1.91%","FiveDayReturnBefore":"-1.35%"},{"Ticker":"CCE","EffectiveDate":"2012-11-16","Type":"RatingNeutral","Title":"CLSA downgrades CCE to Underperform from Outperform.","DailyReturn":"-0.33%","FiveDayReturnAfter":"3.25%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"CCE","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, CCE reports 2012 Q3's earning $0.88 per share and revenue $2070MM..","DailyReturn":"0.51%","FiveDayReturnAfter":"1.44%","FiveDayReturnBefore":"-4.12%"},{"Ticker":"CCE","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCE to Buy. Target Price is $38; previously $35.","DailyReturn":"-0.97%","FiveDayReturnAfter":"0.68%","FiveDayReturnBefore":"0.25%"},{"Ticker":"CCE","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"UBS maintains CCE to Buy. Target Price is $34; previously $32.","DailyReturn":"2.46%","FiveDayReturnAfter":"4.02%","FiveDayReturnBefore":"-3%"},{"Ticker":"CCE","EffectiveDate":"2012-09-05","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.1%","FiveDayReturnAfter":"2.95%","FiveDayReturnBefore":"-0.13%"},{"Ticker":"CCE","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $30; previously $33.","DailyReturn":"2.57%","FiveDayReturnAfter":"10.12%","FiveDayReturnBefore":"-1.77%"},{"Ticker":"CCE","EffectiveDate":"2012-07-23","Type":"RevenueBeat","Title":"Before market open, CCE reports 2012 Q2's earning $0.73 per share and revenue $2208MM. This meets analyst's estimated EPS $0.73, misses estimated revenue $2270MM.","DailyReturn":"2.57%","FiveDayReturnAfter":"10.12%","FiveDayReturnBefore":"-1.77%"},{"Ticker":"CCE","EffectiveDate":"2012-06-06","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"2.44%","FiveDayReturnAfter":"1.85%","FiveDayReturnBefore":"-5.82%"},{"Ticker":"CCE","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCE to Buy. Target Price is $33; previously $32.","DailyReturn":"-0.06%","FiveDayReturnAfter":"-0.97%","FiveDayReturnBefore":"3.97%"},{"Ticker":"CCE","EffectiveDate":"2012-04-26","Type":"EarningsRelease","Title":"Before market open, CCE reports 2012 Q1's earning $0.35 per share and revenue $1868MM..","DailyReturn":"2.16%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"2.36%"},{"Ticker":"CCE","EffectiveDate":"2012-03-07","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"1.69%","FiveDayReturnAfter":"2.76%","FiveDayReturnBefore":"-3.64%"}];